Login to get immediate access to this content.
LoginSpeaker: David Tougeron, France
Abstract discussed:
- Pembrolizumab in combination with xelox and bevacizumab in patients with microsatellite stable (pMMR/MSS) metastatic colorectal cancer (mCRC) and a high immune infiltrate: A proof of concept study - Preliminary results of FFCD 1703 POCHI trial - Watch the session from ESMO Gastrointestinal Cancers Congress 2024 now
The speakers and studies featured in this video series were selected independently by ESMO.
Published July 2024